Stock Price
1,281.90
Daily Change
-18.10 -1.39%
Monthly
-5.03%
Yearly
-15.03%
Q1 Forecast
1,289.06

Cipla reported INR30.35B in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Arca Biopharma USD 4.36M 5.12M Mar/2025
aTyr Pharma USD 4.06M 184K Sep/2025
Bio Path USD 3.48M 1.14M Jun/2025
Brainstorm Cell Therapeutics USD 6.42M 423K Sep/2025
Capricor Therapeutics 1.65M 1.06M Dec/2025
Cara Therapeutics USD 2.42M 2.42M Jun/2025
Cipla INR 30.35B 1.98B Sep/2025
Dr.Reddys Laboratories INR 40.8B 548M Dec/2025
Esperion Therapeutics USD 65.07M 12.44M Dec/2025
Immunic USD 7.92M 25K Sep/2025
Infinity Pharmaceuticals USD 1.5M 433K Jun/2023
Minerva Neurosciences USD 640K 305K Dec/2025
Nektar Therapeutics USD 15.56M 1.28M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Sun Pharmaceuticals INR 67.06B 5.21B Sep/2025
TherapeuticsMD USD 143K 4K Jun/2024
UPL INR 128.97B 20.3B Sep/2025